<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02632890</url>
  </required_header>
  <id_info>
    <org_study_id>IM101-537</org_study_id>
    <nct_id>NCT02632890</nct_id>
  </id_info>
  <brief_title>Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries</brief_title>
  <official_title>Evaluation of the Effectiveness of the Abatacept (Orencia®) IV and SC Patient Alert Cards in Patients With Rheumatoid Arthritis in European Economic Area Countries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bristol-Myers Squibb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine a) if the implementation of abatacept (Orencia®)
      patient alert card (PAC) resulted in effective understanding of key safety messages and b) if
      the degree of understanding of key safety messages is associated with improved clinical and
      safety outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      3 sub studies: 2 Cross-Sectional and 1 retrospective chart review
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 29, 2016</start_date>
  <completion_date type="Actual">April 28, 2017</completion_date>
  <primary_completion_date type="Actual">April 28, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient survey: Proportion of patients treated with abatacept who are aware of the existence of the PAC</measure>
    <time_frame>At patient enrolment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient survey: Proportion of patients treated with abatacept who have received the PAC</measure>
    <time_frame>At patient enrolment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient survey: Proportion of patients who have utilised the PAC, and the extent of its use</measure>
    <time_frame>At patient enrolment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient survey: Levels of patient knowledge and comprehension related to the important identified risks of allergic reactions associated with abatacept treatment</measure>
    <time_frame>At patient enrolment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient survey: Levels of patient knowledge and comprehension related to the important identified risks of associated with abatacept treatment</measure>
    <time_frame>At patient enrolment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient survey: Mean scores for correct responses for questions grouped by objectives</measure>
    <time_frame>At patient enrolment</time_frame>
    <description>Objectives: distribution, awareness, utility, utilization and knowledge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient survey: Mean total score for correct responses</measure>
    <time_frame>At patient enrolment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HCP survey: Proportion of HCPs who prescribe or administer abatacept in rheumatology centers who are aware of the PAC</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HCP survey: Proportion of HCPs' who have utilized the PAC, and the extent of its use</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HCP survey: Levels of HCPs' knowledge and comprehension related to the important identified risks of infections and the need to screen for specific infection prior to initiating or administering abatacept</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HCP survey: Mean total score for correct responses</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HCP survey: Mean scores for correct responses for questions grouped by objectives</measure>
    <time_frame>Day 1</time_frame>
    <description>Objectives: distribution, awareness, utility, utilization and knowledge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retrospective chart review study (clinical outcome study): Proportion of infections leading to hospitalization</measure>
    <time_frame>Approximately 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major determinants of patients knowledge of the key messages contained in the abatacept IV, Subcutaneous (SC) formulation PACs among patients</measure>
    <time_frame>At patient enrolment</time_frame>
    <description>Determinants: Formulation of abatacept administered, country, age, gender,
educational level, duration of arthritis, number of prescription medications, duration of therapy with abatacept, HCP guided or self-administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major determinants of understanding the key messages contained in the abatacept IV, SC formulation PACs among patients</measure>
    <time_frame>At patient enrolment</time_frame>
    <description>Determinants: Formulation of abatacept administered, country, age, gender,
educational level, duration of arthritis, number of prescription medications, duration of therapy with abatacept, HCP guided or self-administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major determinants of implementation regarding the key messages contained in the abatacept IV, SC formulation PACs among patients</measure>
    <time_frame>At patient enrolment</time_frame>
    <description>Determinants: Formulation of abatacept administered, country, age, gender,
educational level, duration of arthritis, number of prescription medications, duration of therapy with abatacept, HCP guided or self-administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determinants of Health Care Professional (HCP) understanding, Implementation regarding key messages contained in the PAC based on data collected in the abatacept IV and SC formulation PACs among HCPs</measure>
    <time_frame>Day 1</time_frame>
    <description>Determinants: type of HCP, role of the HCP, country, age and sex of the HCP, years in the specialty, number of HCPs in the unit, annual number of patients managed by the unit, number of patients for whom abatacept was prescribed in the previous 12 months, type of practice, type of institution (academic or non-academic), size of town</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retrospective chart review study (clinical outcome study): Proportion of patients with results of any test to screen for Tuberculosis (TB) prior to administration of therapy of abatacept</measure>
    <time_frame>Upto 8 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retrospective chart review study (clinical outcome study): Proportion of patients with results of any test to screen for viral hepatitis before administration of therapy with abatacept</measure>
    <time_frame>Upto 8 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retrospective chart review study (clinical outcome study): Mean time from infection (symptom onset) to receiving medical attention</measure>
    <time_frame>Upto 8 years</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">203</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Patients survey</arm_group_label>
    <description>Adult patients treated with abatacept for rheumatoid arthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HCP survey</arm_group_label>
    <description>HCP with at least 1 patient taking abatacept</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retrospective chart review study</arm_group_label>
    <description>Adult patients treated with abatacept for rheumatoid arthritis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort 1: Patients enrolled by physician or nurse based in hospital rheumatology
        departments and physician clinics and offices

        Cohort 2: Physician or nurse based in hospital RA department and physician clinics and
        offices

        Cohort 3: Patients enrolled by physician or nurse based in hospital rheumatology
        departments and physician clinics and offices
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient survey (cohort 1):

               1. Patients has taken abatacept within the previous 3 months for rheumatoid
                  arthritis

               2. Patient is 18 years of age or over

          -  HCP survey (cohort 2):

             a) Physician or nurses working in rheumatology centers, with at least 1 patient taking
             abatacept in the previous 6 months for rheumatoid arthritis (by prescribing,
             administering or by follow up)

          -  Retrospective chart review study (cohort 3):

               1. Patient survey questionnaire completed , Informed Consent Form (ICF) signed

        Exclusion Criteria:

          -  Patient survey:

               1. Patient has participated in a clinical trial for their arthritis in the previous
                  12 months

               2. Currently an employee of BMS

          -  HCP survey:

               1. Physicians or nurse who have recruited patients for the Patient survey

               2. Currently an employee of BMS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bristol-Myers Squibb</last_name>
    <role>Study Director</role>
    <affiliation>Bristol-Myers Squibb</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Limoges - Hopital Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM - Hopital Sainte-Marguerite, Marseille</name>
      <address>
        <city>Paris</city>
        <zip>75571</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Acura Kliniken</name>
      <address>
        <city>Bad Kreuznach</city>
        <zip>55543</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Bad Kreuznach</city>
        <zip>55543</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bad Nauheim</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Frankenberg</city>
        <zip>9669</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69121</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Zwickau</city>
        <zip>8056</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zwickau</name>
      <address>
        <city>Zwickau</city>
        <zip>8056</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Coruña</name>
      <address>
        <city>A Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ccal. de Barbastro</name>
      <address>
        <city>Barbastro</city>
        <zip>22300</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Elche</name>
      <address>
        <city>Elche</city>
        <zip>3203</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Elda</name>
      <address>
        <city>Elda</city>
        <zip>3600</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Elda</city>
        <zip>3600</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Getafe</name>
      <address>
        <city>Getafe</city>
        <zip>28905</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Merida</name>
      <address>
        <city>Merida</city>
        <zip>6800</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Puerto</name>
      <address>
        <city>Plasencia</city>
        <zip>10600</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Plasencia</city>
        <zip>10600</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Mutua de Terrasa</name>
      <address>
        <city>Terrasa</city>
        <zip>8221</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Malmö</city>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Solna</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nevil Hall Hospital</name>
      <address>
        <city>Abergavenny</city>
        <zip>NP7 7EG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Basingstoke</city>
        <zip>RG24 9NA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Derby Hospital</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnsley Hospital NHS Foundation Trust</name>
      <address>
        <city>Dewsbury</city>
        <zip>WF13 4HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastbourne District Gen. Hosp.</name>
      <address>
        <city>East Sussex</city>
        <zip>BN21 2UD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Harlow</city>
        <zip>CM20 1QX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Harlow</city>
        <zip>CM20 1QX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Helens Hospital</name>
      <address>
        <city>St. Helens</city>
        <zip>WA9 3DA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arrow Park Hospital</name>
      <address>
        <city>Wirral</city>
        <zip>CH49 5PE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://bms.com/studyconnect/Pages/home.aspx</url>
    <description>BMS Clinical Trial Patient Recruiting</description>
  </link>
  <link>
    <url>http://www.fda.gov/MEDWATCH/safety.htm</url>
    <description>FDA Safety Alerts and Recalls</description>
  </link>
  <link>
    <url>http://www.bms.com/clinical_trials/Pages/Investigator_inquiry_form.aspx</url>
    <description>Investigator Inquiry Form</description>
  </link>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2015</study_first_submitted>
  <study_first_submitted_qc>December 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2015</study_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abatacept</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

